Researchers from the Epigenetics and Cancer Biology Program (PEBC) led by Dr. Manel Esteller at the Bellvitge Biomedical Research Institute (IDIBELL) have discovered how an epigenetic lesion can lead ...
Read moreThe offering included institutional investors specialized in healthcare and life sciences from the US, Spain and rest of Europe. The majority of the funds were raised from international investors, rei...
Read moreOryzon is finishing an on going double - blind, placebo - controlled Phase 1 clinical trial in healthy volunteer s of its proprietary oral LSD1 - MAOB dual selective inhibitor ORY - 2001. The company ...
Read moreLos resultados, según el profesor Rodríguez, demuestra que pueden usarse enzimas vegetales para reactivar genes silenciados, abriendo así nuevas opciones para estudiar la función de la metilación...
Read moreResearchers led by Salvador Aznar-Benitah at IRB Barcelona investigate the role of Dnmt3a and Dnmt3b proteins in skin homeostasis and tumour development in adult mice. The study has been published in ...
Read moreUn estudio reciente del CIBEROBN, liderado por la doctora Ana Belén Crujeiras, ha demostrado que la obesidad y la menopausia modifican el perfil epigenómico del cáncer de mama. Esta investigación ...
Read moreA research team from the Bellvitge Biomedical Research Institute (IDIBELL) has managed to characterize the complete epigenomes of the most frequent tumors, including those of colon, lung and breast ca...
Read moreThe invention of the EPICUP® epigenetic test last year allowed physicians to elucidate what type of primary tumor had metastasized in patients with Cancer of Unknown Primary (CUP). Today, an article ...
Read moreUna subida de 2°C altera la metilación del ADN y la expresión de genes claves para la supervivencia y el desarrollo. Este estudio ofrece una nueva visión sobre las consecuencias del cambio climát...
Read moreDefectos epigenéticos contribuyen al desarrollo de patologías como la enfermedad de Claes-Jensen o el Síndrome de Rett, ambas ligadas al cromosoma X y asociadas a discapacidad intelectual y comport...
Read moreResearchers of the Chromatin and Disease Group from the Bellvitge Biomedical Research Institute (IDIBELL) in Barcelona have identified a distinctive epigenetic event in immune cells that differentiate...
Read moreUn estudio del CIBEROBN, liderado por Ana Belén Crujeiras, investigadora en el grupo que lidera Felipe Casanueva en el Complejo Hospitalario Universitario de Santiago de Compostela, ha permitido iden...
Read more